HAGH Human

Hydroxyacylglutathione Hydrolase Human Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular Structure and Biological Function

HGH is synthesized in somatotropic cells of the anterior pituitary gland and exists in multiple isoforms. The dominant form is a 22 kDa protein stabilized by two disulfide bonds . Key characteristics include:

PropertyDescription
Molecular Weight22,124 Da
Primary Isoform22 kDa (accounts for ~75% of circulating HGH)
Secretion PatternPulsatile, regulated by GHRH and somatostatin
Biological TargetsLiver (IGF-1 production), adipose tissue (lipolysis), muscle (protein synthesis)

HGH directly stimulates insulin-like growth factor 1 (IGF-1) secretion, mediating its anabolic effects .

Clinical and Performance-Enhancing Applications

HGH is FDA-approved for:

  • Pediatric growth hormone deficiency

  • Adult growth hormone deficiency syndrome

  • HIV-associated wasting

Despite limited evidence for performance enhancement, illicit use persists in sports due to perceived benefits in lean mass accretion and recovery .

Detection Methods in Anti-Doping

Two primary approaches are employed to detect recombinant HGH (rhGH) misuse:

Table 1: HGH Doping Detection Strategies

MethodPrincipleLimitations
Direct (Isoform Analysis)Measures 22 kDa rhGH vs. endogenous isoforms Short detection window (~24–36 hours)
Indirect (Biomarkers)Tracks IGF-1, IGFBP-3, or collagen markers High interindividual variability

The direct method leverages immunoassays to distinguish exogenous 22 kDa rhGH from endogenous isoforms (e.g., 20 kDa variants) .

Table 2: Clinical Pharmacokinetics of rhGH

ParameterValue
Half-life2–3 hours (subcutaneous)
Peak Serum Levels4–6 hours post-injection
MetabolismHepatic and renal clearance

Prolonged supra-physiological dosing correlates with:

  • Acromegaly-like symptoms (jaw growth, organomegaly)

  • Insulin resistance

  • Cardiovascular risks

Regulatory Status and Challenges

AgencyGuideline
FDAApproved only for specific deficiency syndromes
WADAProhibited in- and out-of-competition; blood tests enforced since 2004
NCAABanned substance; penalties for detected use

Efforts to improve detection sensitivity include longitudinal biomarker profiling and isoform ratio algorithms .

Research Frontiers

  • Organoid models: Human stem cell-derived systems screen HGH’s hypertrophic effects .

  • High-throughput toxicology: EPA’s ToxCast program evaluates endocrine-disrupting potential of HGH analogs .

Product Specs

Introduction
Human Hydroxyacylglutathione hydrolase (HAGH) is a member of the glyoxalase family and functions as a thiolesterase. This enzyme plays a crucial role in the detoxification of methylglyoxal, a byproduct of glycolysis, by catalyzing the hydrolysis of S-lactoyl-glutathione to regenerate reduced glutathione and D-lactate. HAGH acts as a target for p63 and p73, functioning as a pro-survival factor within the p53 family. Structurally, HAGH exists exclusively as a monomer, with each subunit binding two zinc ions.
Description
Recombinant human HAGH protein, expressed in E. coli, is a single, non-glycosylated polypeptide chain encompassing 284 amino acids (residues 1-260). The protein has a molecular weight of 31.4 kDa and includes an N-terminal 24 amino acid His-tag to facilitate purification. Purification is achieved using proprietary chromatographic techniques.
Physical Appearance
Clear, sterile-filtered solution.
Formulation
The HAGH protein is supplied as a 0.5 mg/mL solution in 20 mM Tris-HCl buffer (pH 8.5) containing 10% glycerol.
Stability
For short-term storage (up to 2-4 weeks), the protein should be stored at 4°C. For extended storage, it is recommended to store the protein at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is advisable for long-term storage. Repeated freeze-thaw cycles should be avoided.
Purity
The purity of HAGH is greater than 95% as determined by SDS-PAGE analysis.
Synonyms
GLX2, Glyoxalase II, GLO2, Hydroxyacyl Glutathione Hydrolase, HAGH1, GLXII, Hydroxyacylglutathione Hydrolase, hydroxyacylglutathione hydroxylase.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMKVEVL PALTDNYMYL VIDDETKEAA IVDPVQPQKV VDAARKHGVK LTTVLTTHHH WDHAGGNEKL VKLESGLKVY GGDDRIGALT HKITHLSTLQ VGSLNVKCLA TPCHTSGHIC YFVSKPGGSE PPAVFTGDTL FVAGCGKFYE GTADEMCKAL LEVLGRLPPD TRVYCGHEYT INNLKFARHV EPGNAAIREK LAWAKEKYSI GEPTVPSTLA EEFTYNPFMR VREKTVQQHA GETDPVTTMR AVRREKDQFK MPRD.

Q&A

What is the HAGH gene and what does it encode in humans?

The Human hydroxyacylglutathione hydrolase (HAGH) gene encodes glyoxalase II, a critical enzyme in cellular detoxification pathways. Unlike in yeast and plants where separate genes encode cytosolic and mitochondrial forms, mammals possess a single HAGH gene that produces two distinct protein forms through alternative transcription and translation mechanisms. This gene gives rise to both cytosolic and mitochondrial variants of glyoxalase II through a sophisticated regulatory process involving alternative exon utilization .

How are the different HAGH transcripts structured?

Research has demonstrated that the HAGH gene produces two distinct mRNA species through differential exon utilization. The first transcript derives from 9 exons and remarkably encodes both the mitochondrial and cytosolic forms of glyoxalase II. The second transcript comprises 10 exons and contains an in-frame termination codon between two initiating AUG codons, resulting in expression of only the cytosolic enzyme form . When designing experiments to study HAGH transcript expression, researchers should implement appropriate controls and standardized methodologies to account for this complexity .

What experimental approaches are recommended for initial HAGH characterization?

For researchers beginning work with HAGH, a systematic experimental approach is essential. First, establish reliable detection methods for both protein variants using isoform-specific antibodies or tagged constructs. Design factorial experiments examining expression across relevant tissues and conditions, with appropriate statistical power calculations to determine sample sizes. Consider implementing a 2×3 design (two protein variants × three cellular conditions) with dependent variables including enzymatic activity, protein abundance, and subcellular distribution . Always include appropriate positive and negative controls to validate experimental findings.

What mechanisms govern the dual localization of HAGH-encoded proteins?

The dual localization of HAGH-encoded proteins stems from a sophisticated translational regulation mechanism. The 9-exon transcript harbors two functional AUG start codons with distinct roles: the upstream AUG initiates translation of the mitochondrially-targeted form, while a downstream AUG serves as an internal ribosome entry site producing the cytosolic variant. Confocal microscopy confirms that the mitochondrial form localizes specifically to the mitochondrial matrix . When investigating this phenomenon, researchers should employ within-subject experimental designs comparing expression patterns across multiple cell types and conditions, while controlling for potential carryover effects through counterbalanced experimental protocols .

How should researchers design experiments to distinguish between HAGH isoforms?

When designing experiments to distinguish between HAGH isoforms, implement a multi-method approach combining:

MethodologyApplication to HAGH ResearchAnalytical Considerations
Subcellular fractionationSeparate mitochondrial and cytosolic componentsRequires validation of fraction purity
Isoform-specific antibodiesDetect unique epitopes on each variantValidate specificity with knockout controls
Fluorescence microscopyVisualize subcellular localizationConfirm colocalization with organelle markers
Mass spectrometryIdentify isoform-specific peptidesStatistical validation of peptide assignments

For statistical analysis, implement a multi-factor ANOVA design to assess differences between isoforms across experimental conditions, with post-hoc tests to examine specific contrasts of interest .

What evolutionary significance does HAGH's dual targeting mechanism have?

The evolutionary conservation of HAGH's dual targeting mechanism across vertebrates suggests strong selective pressure maintaining this arrangement . When investigating the evolutionary aspects of HAGH, researchers should design comparative studies examining sequence conservation, expression patterns, and functional characteristics across diverse species. Implement phylogenetic analysis methods combined with experimental validation in multiple model organisms. Statistical approaches should include comparative sequence analysis methods and tests for selective pressure on key regulatory elements governing the dual targeting mechanism .

How should researchers approach statistical analysis of HAGH expression data?

For robust statistical analysis of HAGH expression data, researchers should:

  • Begin with appropriate experimental design considering within-subject vs. between-subject factors depending on research questions

  • Test for normality of data distribution before selecting parametric or non-parametric tests

  • Account for potential confounding variables through proper experimental controls

  • For complex designs examining multiple conditions, implement factorial ANOVA with appropriate post-hoc tests

  • Consider implementing Latin square counterbalancing when testing sequential treatments to minimize carryover effects

Remember that causality cannot be definitively proven - experiments can only provide evidence supporting correlations between treatments and outcomes while eliminating alternative explanations .

What are the best practices for designing human studies involving HAGH biomarkers?

When designing human studies involving HAGH biomarkers, researchers must consider both methodological rigor and ethical considerations:

  • Develop clear inclusion/exclusion criteria based on relevant demographic, clinical, and genetic factors

  • Calculate appropriate sample size based on expected effect sizes and desired statistical power

  • Implement randomized controlled designs where possible to minimize bias

  • Establish standardized protocols for sample collection, processing, and analysis

  • Ensure all protocols receive proper human subjects approval and informed consent from participants

For large-scale population studies, consider implementing stratified sampling approaches as used in national surveys like NSDUH to ensure representative data across demographic variables .

How can researchers effectively control for confounding variables in HAGH functional studies?

To effectively control for confounding variables in HAGH functional studies:

  • Implement randomized assignment to experimental conditions

  • Use matched controls when comparing different cell lines or tissue samples

  • Standardize experimental protocols, including reagent preparations and incubation times

  • Account for potential cellular stress responses that might independently affect HAGH function

  • Consider using genetic approaches (knockout/knockin models) to establish causality rather than correlation

  • Implement appropriate statistical methods to control for identified covariates in analysis

Remember that even carefully designed experiments can have unexpected confounds, so researchers should critically evaluate their assumptions throughout the research process .

What methodological approaches are recommended for studying HAGH in disease models?

When investigating HAGH in disease models, implement a multi-tiered research strategy:

  • Begin with in vitro studies using relevant cell lines to establish baseline mechanisms

  • Progress to animal models that recapitulate key aspects of human disease

  • Design experiments with appropriate controls (positive, negative, vehicle)

  • Consider both loss-of-function and gain-of-function approaches

  • Implement time-course analyses to capture dynamic changes in HAGH activity

  • Use multiple complementary methods to measure HAGH function (enzymatic activity, protein levels, localization)

Statistical analysis should include appropriate models for repeated measures when tracking disease progression, with careful attention to potential confounding variables .

How should researchers approach contradictory findings in HAGH literature?

When confronted with contradictory findings in HAGH literature:

  • Systematically evaluate methodological differences between studies, including:

    • Experimental models used (cell lines, animal models, human samples)

    • Analytical techniques employed

    • Statistical approaches and sample sizes

  • Design validation experiments that specifically address key discrepancies, implementing:

    • Multiple independent methodologies

    • Rigorous controls

    • Blinded analysis procedures

    • Sufficient statistical power to detect relevant effects

  • Consider potential biological explanations for discrepancies, such as:

    • Cell type-specific regulation

    • Environmental or experimental conditions

    • Genetic background differences

In your experimental design, implement factorial approaches that specifically test hypothesized explanations for contradictions .

What emerging technologies might advance HAGH research?

Emerging technologies with significant potential for advancing HAGH research include:

  • CRISPR-based gene editing for precise manipulation of HAGH regulatory elements

  • Single-cell multi-omics approaches to examine cell-specific HAGH expression patterns

  • Advanced imaging techniques such as super-resolution microscopy for detailed localization studies

  • Computational modeling of HAGH interactions within metabolic networks

  • High-throughput screening platforms for identifying compounds that modulate HAGH activity

When implementing these technologies, researchers should design appropriate control experiments and validation strategies to confirm findings across multiple methodological approaches .

How can researchers effectively integrate multi-omics data in HAGH studies?

For effective integration of multi-omics data in HAGH research:

  • Design studies that collect matched samples for different omics analyses (genomics, transcriptomics, proteomics, metabolomics)

  • Implement appropriate normalization procedures for each data type

  • Apply statistical methods specifically designed for multi-omics integration, such as:

    • Canonical correlation analysis

    • Network-based integration approaches

    • Multi-block partial least squares methods

  • Validate key findings using orthogonal experimental approaches

  • Consider potential technical biases in each omics platform and implement appropriate quality control measures

This integrated approach provides a comprehensive understanding of HAGH biology across multiple molecular levels, revealing insights that might be missed by single-omics approaches .

Product Science Overview

Structure and Function

Hydroxyacylglutathione hydrolase is classified as a thiolesterase and is responsible for the hydrolysis of S-lactoyl-glutathione to reduced glutathione and D-lactate . The enzyme’s systematic name is S-(2-hydroxyacyl)glutathione hydrolase . The reaction it catalyzes is as follows:

S(2hydroxyacyl)glutathione+H2Oglutathione+a2hydroxycarboxylateS-(2-hydroxyacyl)glutathione + H_2O \rightarrow glutathione + a 2-hydroxy carboxylate

This reaction is essential for maintaining cellular redox balance and protecting cells from oxidative stress .

Genetic and Molecular Information

The HAGH gene is located on chromosome 16p13.3 in humans . The gene spans approximately 21.5 kilobases and consists of multiple exons . The enzyme encoded by this gene has a molecular mass of approximately 28,861 Da and consists of 260 amino acids .

Expression and Localization

Hydroxyacylglutathione hydrolase is expressed in various tissues, with high expression levels observed in the liver, kidney, and muscle tissues . The enzyme is localized primarily in the cytoplasm and mitochondria, where it performs its detoxification function .

Recombinant Production

Human recombinant hydroxyacylglutathione hydrolase is produced using recombinant DNA technology. The gene encoding the enzyme is cloned into an expression vector, which is then introduced into a suitable host organism, such as Escherichia coli. The host cells express the enzyme, which is subsequently purified using various chromatographic techniques .

Clinical Significance

Deficiency or malfunction of hydroxyacylglutathione hydrolase can lead to the accumulation of methylglyoxal, resulting in cellular damage and contributing to various diseases, including diabetes and neurodegenerative disorders . Understanding the enzyme’s structure and function is crucial for developing therapeutic strategies to mitigate these conditions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.